Advances in Transitioning from Batch to Continuous Flow

Organizers: Tim Braden, Research Scientist, Lilly; Tony Didomenico, Abbvie; Paul Richardson, Pfizer

Despite the exponential growth of research into continuous manufacturing techniques, the production of specialty chemicals and specifically pharmaceuticals is still largely dependent on batch processes. However, sustainability and logistical considerations suggests that this trend is slowly changing, though several technical hurdles still exist in transitioning to a continuous process.  This session on Flow Chemistry and Continuous Manufacturing provides an opportunity to see a number of the field’s current leading practitioners from academia and industry presenting their research, with a focus on providing solutions that enable a seamless transition of a chemical process from batch to flow.

Tags: